SINGAPORE -- Businessman Dato Shaun Lim was a successful real estate mogul until he suddenly decided to switch careers in 2019. Flicking through the movie list on an international flight, he chanced to watch a documentary about "geroscience" -- the study of aging and how it can be stopped. That struck Lim as a rather good business proposition. Later that year, Lim would co-found Regenosis, a clinic and geroscience research company, devoted to stem cell therapies designed to halt or reverse the aging process.
A scientist at Star Clinic, a regenerative medical center in Tokyo, transfers cells extracted from a patient to a container for use in stem cell therapy. (Photo by Yuki Kohara)
The Big Story
Defying death: Japan and Singapore lead Asia's stem cell research race
In the world's fastest-aging societies, regenerative therapies attract the rich and curious
Read Next
.jpg?width=178&fit=cover&gravity=faces&dpr=2&quality=medium&source=nar-cms&format=auto&height=100)
Latest on The Big Story
